Despite large numbers of prescriptions written by general practitioners at enormous cost, mostly borne by the National Health Service, the information available to doctors about their prescribing until recently has been minimal. Many doctors who have wished to audit their own prescribing have had to supplement the available information by resorting to tedious analysis of…
European Journal Of Haematology Template
Write in a clean editor, then format for European Journal Of Haematology in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the European Journal Of Haematology format
European Journal Of Haematology is a peer-reviewed journal published by Wiley, covering Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." European Journal Of Haematology 12 (3): 45–58.
Formats any DOI in European Journal Of Haematology style. No sign-up. |
| Publishes research in | Acute Myeloid Leukemia Research Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research Multiple Myeloma Research and Treatments Hemoglobinopathies and Related Disorders |
| ISSN | 0902-4441 |
| Citation impact (2-yr) | 1.9 |
| h-index | 120 |
| i10-index | 3,751 |
| Total citations | 143,805 |
| Article processing charge | $4,220 |
| Top institutions publishing here | Rigshospitalet |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in European Journal Of Haematology per year
Citation impact of European Journal Of Haematology by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in European Journal Of Haematology
The purpose of the present study was to analyse the importance and prognostic value of renal failure in multiple myeloma patients. The frequency and reversibility of renal failure in 775 multiple myeloma patients diagnosed between 1984-86 and 1990-92 in the Nordic countries were studied. Renal failure, defined as plasma creatinine > 130 micromol/l, was observed…
In the light of the enthusiasm regarding the use of recombinant human erythropoietin (Epo) and its analogues for treatment of the anaemias of chronic renal failure and malignancies it is worth remembering that today's success has been based on a century of laborious research. The concept of the humoral regulation of haematopoiesis was first formulated…
β-thalassemia major is an inherited hemoglobinopathy that requires lifelong red blood cell transfusions and iron chelation therapy to prevent complications due to iron overload. Traditionally, β-thalassemia has been more common in certain regions of the world such as the Mediterranean, Middle East, and Southeast Asia. However, the prevalence of β-thalassemia is increasing in other regions,…
Soluble tumour necrosis factor receptors (sTNF-Rs) play a role as modulators of the biological function of tumour necrosis factor-alpha (TNF-alpha) in an agonist/antagonist pattern. In various pathologic states the production and release of sTNF-Rs may mediate host response and determine the course and outcome of disease by interacting with TNF-alpha and competing with cell surface…